0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Challenge | 
Jarad Levin, MD; Timothy Hofstra, MD
JAMA. 2014;312(4):426-427. doi:10.1001/jama.2014.3611.

Research Letter | 
Yaron Finkelstein, MD, ABCP(Dip); Erin M. Macdonald, MSc; Ping Li, PhD; et al.
JAMA. 2014;311(21):2231-2232. doi:10.1001/jama.2014.839.

JAMA Clinical Challenge | 
Emma F. Johnson, BA; Michaela H. Jacobs, MD; Aimee C. Smidt, MD
JAMA. 2013;310(23):2559-2560. doi:10.1001/jama.2013.283530.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(8):785. doi:10.1001/jama.2013.276938.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;309(4):333. doi:10.1001/jama.2013.22.

JAMA Clinical Challenge | 
Huan J. Chang, MD, MPH
JAMA. 2011;306(7):767-768. doi:10.1001/jama.2011.1135.

Health Agencies Update | 
Bridget M. Kuehn
JAMA. 2009;301(24):2542. doi:10.1001/jama.2009.859.

From the Food and Drug Administration | 
Bernard A. Schwetz, DVM, PhD
JAMA. 2001;285(13):1696. doi:10.1001/jama.285.13.1696-JFD10003-3-1.

Research Opportunities for Specific Diseases and Disorders |  FREE
Grant J. Anhalt, MD; Luis A. Diaz, MD
JAMA. 2001;285(5):652-654. doi:10.1001/jama.285.5.652.

Grand Rounds | 
Kim B. Yancey, MD; Conleth A. Egan, MB, MRCPI
JAMA. 2000;284(3):350-356. doi:10.1001/jama.284.3.350.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Perspective  | 
More Than Skin Deep—The Costs of Antibiotic Overuse:  A Teachable Moment
Vinod E. Nambudiri, MD, MBA
JAMA Dermatology
Case Report/Case Series  | 
Subcutaneous Veltuzumab, a Humanized Anti-CD20 Antibody, in the Treatment of Refractory Pemphigus Vulgaris
Christoph T. Ellebrecht, MD; Eun J. Choi, BS; David M. Allman, PhD; et al.
JAMA Dermatology
The Cutting Edge  | 
Epidermal Grafting Using a Novel Suction Blister–Harvesting System for the Treatment of Pyoderma Gangrenosum
Nicholas A. Richmond, MD; Sonia A. Lamel, MD; Liza R. Braun, MD; et al.
JAMA Dermatology
Case Report/Case Series  | 
High Anti–Desmoglein 3 Antibody ELISA Index and Negative Indirect Immunofluorescence Result in a Patient With Pemphigus Vulgaris in Remission:  Evaluation of the Antibody Profile by Newly Developed Methods
Tomoko Nakahara, MD; Atsushi Takagi, MD, PhD; Jun Yamagami, MD, PhD; et al.